Cardiovascular Disease and Risk Management

被引：181

作者：

不详

机构：

来源：

DIABETES CARE | 2015年 / 38卷

关键词：

TYPE-2; DIABETES-MELLITUS; CORONARY-HEART-DISEASE; CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC FUNCTION; LOWERING LDL CHOLESTEROL; BLOOD-PRESSURE CONTROL; 14; RANDOMIZED-TRIALS; PRIMARY PREVENTION; STATIN THERAPY; ASYMPTOMATIC PATIENTS;

D O I：

10.2337/dc15-S011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S49 / S57

页数：9

共 78 条

[41] Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) [J].

Knopp, Robert H. ;

D'Emden, Michael ;

Smilde, Johan G. ;

Pocock, Stuart J. .

DIABETES CARE, 2006, 29 (07) :1478-1485

[42] Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Lindholm, LH ;

Ibsen, H ;

Dahlöf, B ;

Devereux, RB ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Julius, S ;

Kjeldsen, SE ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H ;

Aurup, P ;

Edelman, J ;

Snapinn, S .

LANCET, 2002, 359 (9311) :1004-1010

[43] Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus Systematic Review and Meta-analysis [J].

McBrien, Kerry ;

Rabi, Doreen M. ;

Campbell, Norm ;

Barnieh, Lianne ;

Clement, Fiona ;

Hemmelgarn, Brenda R. ;

Tonelli, Marcello ;

Leiter, Lawrence A. ;

Klarenbach, Scott W. ;

Manns, Braden J. .

ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (17) :1296-1303

[44] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial [J].

McMurray, JJV ;

Östergren, J ;

Swedberg, K ;

Granger, CB ;

Held, P ;

Michelson, EL ;

Olofsson, B ;

Yusuf, S ;

Pfeffer, MA .

LANCET, 2003, 362 (9386) :767-771

[45] Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study [J].

Meek, Claire ;

Wierzbicki, Anthony S. ;

Jewkes, Christina ;

Twomey, Patrick J. ;

Crook, Martin A. ;

Jones, Alan ;

Viljoen, Adie .

CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) :371-378

[46] The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials [J].

Mihaylova, B. ;

Emberson, J. ;

Blackwell, L. ;

Keech, A. ;

Simes, J. ;

Barnes, E. H. ;

Voysey, M. ;

Gray, A. ;

Collins, R. ;

Baigent, C. ;

de Lemos, J. ;

Braunwald, E. ;

Blazing, M. ;

Murphy, S. ;

Downs, J. R. ;

Gotto, A. ;

Clearfield, M. ;

Holdaas, H. ;

Gordon, D. ;

Davis, B. ;

Koren, M. ;

Dahlof, B. ;

Poulter, N. ;

Sever, P. ;

Knopp, R. H. ;

Fellstrom, B. ;

Holdaas, H. ;

Jardine, A. ;

Schmieder, R. ;

Zannad, F. ;

Goldbourt, U. ;

Kaplinsky, E. ;

Colhoun, H. M. ;

Betteridge, D. J. ;

Durrington, P. N. ;

Hitman, G. A. ;

Fuller, J. ;

Neil, A. ;

Wanner, C. ;

Krane, V. ;

Sacks, F. ;

Moye, L. ;

Pfeffer, M. ;

Hawkins, C. M. ;

Braunwald, E. ;

Kjekshus, J. ;

Wedel, H. ;

Wikstrand, J. ;

Barter, P. ;

Keech, A. .

LANCET, 2012, 380 (9841) :581-590

[47] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial [J].

Nissen, SE ;

Tuzcu, EM ;

Schoenhagen, P ;

Brown, BG ;

Ganz, P ;

Vogel, RA ;

Crowe, T ;

Howard, G ;

Cooper, CJ ;

Brodie, B ;

Grines, CL ;

DeMaria, AN .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09) :1071-1080

[48] Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial [J].

Ogawa, Hisao ;

Nakayama, Masafumi ;

Morimoto, Takeshi ;

Uemura, Shiro ;

Kanauchi, Masao ;

Doi, Naofumi ;

Jinnouchi, Hideaki ;

Sugiyama, Seigo ;

Saito, Yoshihiko .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (18) :2134-2141

[49] Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial [J].

Patel, A. ;

MacMahon, S. ;

Chalmers, J. ;

Neal, B. ;

Woodward, M. ;

Billot, L. ;

Harrap, S. ;

Poulter, N. ;

Marre, M. ;

Cooper, M. ;

Glasziou, P. ;

Grobbee, D. E. ;

Hamet, P. ;

Heller, S. ;

Liu, L. S. ;

Mancia, G. ;

Mogensen, C. E. ;

Pan, C. Y. ;

Rodgers, A. ;

Williams, B. .

LANCET, 2007, 370 (9590) :829-840

[50]

Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1007/s12529-012-9242-5, 10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092]

← 1 2 3 4 5 6 7 8 →